SINGULAIR Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "SINGULAIR Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

SINGULAIR Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on SINGULAIR and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• FDA Paragraph IV patent challenges
• District Court patent litigation
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Annual sales revenues
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

Topics Covered

• Profile for SINGULAIR
• US Patents
• Expired US Patents
• Paragraph IV Patent Challenges
• US District Court Litigation
• International (ex US) Patents
• Supplementary Protection Certificates
• Clinical Trials
• Drug Prices - Average Pharmacy Cost
• Drug Prices - Best Wholesale Price
• Annual Sales Revenues
• Finished Product Suppliers
• Bulk API Sources

Companies Featured

• Merck Sharp & Dohme Corp.
• Msd Merck Co
• Prasco Laboratories
• Rebel Distributors Corp
• Bryant Ranch Prepack
• Dispensing Solutions Inc.
• Novoseek
• Abi Chem
• Chemmol
• Chembase.Cn
• Acesobio
• Act Chemical
• An Pharmatech
• Avachem Scientific
• Race Chemical
• Akos Consulting & Solutions
• Boc Sciences
• Zinc
• Targetmol
• Achemo Scientific Limited
• Clearsynth
• Molepedia
• Ichemical Technology USA Inc
• Pi Chemicals
• Acorn Pharmatech Product List
• Labseeker
• Ochem
• Labnetwork
• A Wuxi Apptec Company
• Chemieliva Pharmaceutical Co. Ltd
• Molport
• Musechem
• Biochempartner
• Hairui Chemical

For more information about this report visit https://www.researchandmarkets.com/research/k396cj/singulair_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005402/en/